Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01158027
Other study ID # SHEBA-10-7999-OK-CTIL
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 4, 2010
Last updated October 17, 2011
Start date October 2011

Study information

Verified date October 2011
Source Sheba Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Observational

Clinical Trial Summary

The goal of the present study is to look at the effect of changing walking parameters on the dynamic walking characteristics among children post severe traumatic brain injury, and typically developed controls.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 8 Years to 13 Years
Eligibility Inclusion Criteria:

1. post-severe closed head injury (Glasgow Coma Scale [GCS] score at admission to emergency room of =8) [Kathryn 2008].

2. at least one year post trauma.

3. ages 7 to 13 years.

4. independent ambulation (foot orthoses permitted).

Exclusion Criteria:

1. had received botulinum toxin for spasticity management or had undergone orthopedic surgery in the past six months.

2. unable to follow simple instructions.

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
gait evaluation
The children will asked to walk under different conditions: (1) walking at a self-selected speed faster and slower on the GAITRite® system and on a treadmill and while listening and to a metronomeQuoting.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sheba Medical Center
See also
  Status Clinical Trial Phase
Recruiting NCT05618509 - Immediate Effects of STENDO on the Walking Abilities of Patients With COPD (STENDO-COPD) N/A